About Fleming Laboratories
Fleming Laboratories is a company based in Hyderabad (India) founded in 1995. Fleming Laboratories has raised $14.33 million across 2 funding rounds from investors including InvAscent, Galt Pharma Exports and Shivasfarmacasa. The company has 271 employees as of August 06, 2024. Fleming Laboratories offers products and services including Active Pharmaceutical Ingredients (APIs) and Sustainability Frameworks.
- Headquarter Hyderabad, India
- Employees 271 as on 06 Aug, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fleming Laboratories Limited
- Jurisdiction Shivampet Mandal, Telangana, India
-
Annual Revenue
$18.86 M (USD)13.37as on Mar 31, 2023
-
Net Profit
$3.02 M (USD)14.48as on Mar 31, 2023
-
EBITDA
$4.35 M (USD)12.82as on Mar 31, 2023
-
Total Equity Funding
$14.33 M (USD)
in 2 rounds
-
Latest Funding Round
$13.24 M (USD), Private Equity Round
Dec 19, 2023
-
Investors
InvAscent
& 3 more
-
Employee Count
271
as on Aug 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fleming Laboratories
Fleming Laboratories offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients (APIs) and Sustainability Frameworks.
Generic Active Pharmaceutical Ingredients are manufactured and supplied for use in the global Pharmaceutical Industry
Frameworks are implemented for reducing carbon footprint, conserving water, minimizing waste, and developing green belts
Funding Insights of Fleming Laboratories
Fleming Laboratories has successfully raised a total of $14.33M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $13.24 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fleming Laboratories
Fleming Laboratories has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include InvAscent, Galt Pharma Exports and Shivasfarmacasa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Fleming Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fleming Laboratories
Investment portfolio details for Fleming Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fleming Laboratories
Detailed financials for Fleming Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fleming Laboratories Comparisons
Peer comparison for Fleming Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fleming Laboratories
Detailed competitors of Fleming Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fleming Laboratories
Complete news archive for Fleming Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fleming Laboratories
Fleming Laboratories was founded in 1995 and raised its 1st funding round 18 years after it was founded.
Fleming Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Jeyamuruga Prakash M is the current CEO of Fleming Laboratories.
Fleming Laboratories is a funded company, having raised a total of $14.33M across 2 funding rounds to date.
As of Aug 06, 2024, the latest employee count at Fleming Laboratories is 271.
Annual revenue of Fleming Laboratories is $18.86M as on Mar 31, 2023.
Fleming Laboratories was founded in 1995 and is headquartered in Hyderabad, India. Operations are centered in the pharmaceutical sector, where active pharmaceutical ingredients (APIs) that are niche and unconventional are developed, manufactured, and exported internationally. The company maintains a focus on specialized production processes to meet global demand for such products, with leadership provided by CEO and Managing Director Jeyamuruga Prakash M.
Fleming Laboratories offers Active Pharmaceutical Ingredients (APIs) and Sustainability Frameworks.
Fleming Laboratories has 4 investors. Key investors include InvAscent, Galt Pharma Exports, Shivasfarmacasa, and B Shiva Kumar.
The valuation of Fleming Laboratories is $10.87M as of Jun 2013.